Also trades as: ESLA (NASDAQ) · $vol 0M
ESLAW Earnings
Estrella Immunopharma, Inc.
1W: -1.0%
1M: -51.4%
3M: -11.7%
YTD: -26.4%
1Y: -4.1%
$0.07
+0.01 (+10.33%)
Weekly Expected Move ±44.8%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Last Earnings
2026-08-13
EPS
$-0.05
▲ Beat +0.0%
Revenue
—
Next Earnings
2026-12-02
EPS Estimate
$-0.07
Range: $-0.07 - $-0.07
Estimate vs Actual
Earnings Surprise History
5/9
EPS Beats
0/9
Revenue Beats
56%
EPS Beat Rate
0%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-08-31 | quarter | 2026-06-30 | $-0.09 | $-0.05 | ▲ 0.04 | $— | $— |
| 2026-08-14 | quarter | 2026-12-30 | $-0.12 | $-0.07 | ▲ 0.05 | $— | $— |
| 2026-07-16 | quarter | 2026-06-30 | $-0.08 | $-0.09 | ▼ 0.01 | $— | $— |
| 2026-07-16 | quarter | 2026-09-30 | $-0.12 | $-0.08 | ▲ 0.04 | $— | $— |
| 2026-07-16 | quarter | 2026-12-31 | $-0.12 | $-0.07 | ▲ 0.05 | $— | $— |
| 2026-04-27 | quarter | 2026-06-30 | $-0.17 | $-0.08 | ▲ 0.09 | $— | $— |
| 2026-04-27 | quarter | 2026-03-31 | $-0.18 | $-0.08 | ▲ 0.10 | $— | $— |
| 2026-03-30 | quarter | 2026-03-31 | $-0.13 | $-0.18 | ▼ 0.05 | $— | $— |
| 2026-03-30 | quarter | 2026-06-30 | $-0.12 | $-0.17 | ▼ 0.05 | $— | $— |
| 2026-03-23 | quarter | 2028-03-31 | $— | $-0.03 | ▼ 0.03 | $— | $25,705,500 |
| 2026-03-23 | quarter | 2027-12-31 | $— | $-0.04 | ▼ 0.04 | $— | $23,728,200 |
| 2026-03-23 | quarter | 2026-03-31 | $— | $-0.13 | ▼ 0.13 | $— | $— |
| 2026-03-23 | quarter | 2025-12-31 | $— | $-0.18 | ▼ 0.18 | $— | $— |
| 2026-03-23 | quarter | 2027-03-31 | $— | $-0.12 | ▼ 0.12 | $— | $— |
| 2026-03-23 | quarter | 2026-12-31 | $— | $-0.12 | ▼ 0.12 | $— | $— |
Earnings Call Transcripts
No transcripts available.